Evidence map›Paper›PMID 41083725›Full record

ArticleThe AAPS journal2025

Effective Visualizations Using "vachette" to Assess and Communicate Pharmacometric Model Results.

Jos Lommerse, Anna Largajolli, James Craig, Nele Plock, S Y Amy Cheung, Jeffrey R Sachs

Abstract read
PubMed Publisher
In one paragraph

Article in The AAPS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Visual Predictive Check and Real-World Data.Clinical pharmacology and therapeutics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jos Lommerse *Certara, Radnor, 4 Radnor Corporate Center Suite 350, Radnor, Pennsylvania, 19087, USA.
Anna Largajolli *Certara, Radnor, 4 Radnor Corporate Center Suite 350, Radnor, Pennsylvania, 19087, USA.
James CraigCertara, Radnor, 4 Radnor Corporate Center Suite 350, Radnor, Pennsylvania, 19087, USA. james.craig@certara.com.
Nele PlockCertara, Radnor, 4 Radnor Corporate Center Suite 350, Radnor, Pennsylvania, 19087, USA.
S Y Amy CheungCertara, Radnor, 4 Radnor Corporate Center Suite 350, Radnor, Pennsylvania, 19087, USA.
Jeffrey R Sachs *Quantitative Pharmacology and Pharmacometrics, Research Laboratories of Merck & Co., Inc, 126 E. Lincoln Ave, Rahway, New Jersey, 07065, USA. jeff_sachs@merck.com.ORCID 0000-0001-5725-558X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using pharmacometrics to inform drug discovery and development decisions requires effective communication of models and data to all stakeholders. The new "vachette" visualization method presented here enables modelers and non-modelers to see how a model integrates and represents all data across relevant subgroups, showing how the model "sees" the data when it accounts for covariates. Vachette starts with user-provided model simulations ("curves"), together with observations used in creating (or otherwise relevant to) the model. It automatically produces a single, intuitive plot overlaying all observations onto a user-selected reference curve, accounting for covariate effects and preserving remaining random effects. The method automatically identifies characteristic landmarks (e.g., minima, maxima, and inflection points) which are used to split each curve into segments. A transformation on both x- and y-axes is then applied to each segment and its corresponding observations, accounting for covariate effects by aligning the segments to the reference, allowing intuitive visualization in one plot of covariate effects and of model fit to the data, preserving the distance between model predictions and the observations. Vachette-transformed data can also be used to enhance the utility of model assessments such as visual predictive checks and residual plots. Model visualizations using vachette enable easier and more effective evaluation and communication of the pharmacometric results critical to informing key decisions. Here the vachette method is described and its utility and flexibility are demonstrated through application to multiple types of pharmacometrics models, suggesting that vachette is a useful addition to the pharmacometrician's toolbox.

Indexed as

Drug DevelopmentDrug DiscoveryModels, BiologicalComputer SimulationHumansmodel diagnosticsmodeling and simulationmodel visualization and communicationpharmacometricsvisual predictive check (VPC)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.